Abstract
In recent years, metal oxides have been studied as an encapsulating matrix nevertheless, few studies the effect that can exist between different precursors to form this type of nanomaterials; In this paper, we compare its ability as a mangiferin (MG) nanoencapsulated. Phytochemical that has been studied for its generous biological properties like anti-inflammatory, antiproliferative, and others; the nanoparticles (NP’s) be synthesized with zinc nitrate and zinc acetate. The results showed modifications in the morphology of the ZnO associated with the precursor but, there is no significant difference between any treatment that is associated with antitopoisomerase activity however, ZnOA-MG is statistically the best treatment by reducing in greater proportion the production of COX-II prostaglandins (97.38 ± 7.09%) with a significant difference (p < 0.05) compared toCOX-I (68.02 ± 2.14%) but, it is not considered a selective treatment moreover ZnOA-MG proved to be the least hepatotoxic (IC50, 140.19 ± 13.10 µg/mL) while ZnON is the most cytotoxic for HEP-G2 and BEAS-2B (IC50, 51.27 ± 4.72 and 26.91 ± 3.21 µg/mL). All treatments change the morphology of erythrocytes to low concentrations (25 µg/mL). Therefore the MG load benefits the biological impact of ZnO.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
